TreeFrog Therapeutics
Bordeaux, FranceWebsite
Specializing in cell therapy and stem cell research using proprietary technology for large-scale production.
Company-aware practice
Start company interviewLoading company information...
Specializing in cell therapy and stem cell research using proprietary technology for large-scale production.
Company context
TreeFrog Therapeutics prompts can include culture, product, and business context from this profile.
Role targeting
Pair this profile with an open role to generate focused behavioral and technical questions.
Answer coaching
Practice responses, get feedback, and refine stories before applying or interviewing.
TreeFrog Therapeutics is a pioneering French biotechnology company dedicated to revolutionizing regenerative medicine through its proprietary C-Stem™ technology. Founded in 2018, the company addresses the critical manufacturing, cost, and quality challenges that have historically hindered the widespread adoption of cell therapies. By utilizing biomimetic 3D encapsulation, TreeFrog enables the large-scale, high-quality production of stem cells, aiming to make advanced treatments accessible to large patient populations globally.
The company's mission is 'Cell Therapy for all,' with a vision to unlock the potential of regenerative medicine by overcoming the manufacturing hurdles that currently limit the scalability and affordability of cell-based treatments.
Founded
2018
Headquarters
Pessac, France
Employees
100-250
Industry
Biotechnology
Opportunity to work at the cutting edge of regenerative medicine and stem cell research.
Collaborative environment with international hubs in the US and Japan.
Strong financial backing and high-profile industry partnerships.
Funding
Over $100 million USD
CEO
Mark Rothera
High-pressure environment typical of a fast-growing biotech startup.
Complex regulatory and clinical trial hurdles inherent to the cell therapy industry.